FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus ...

Pregnant women will be offered free RSV vaccines as part of the National Immunisaton Program from February 3, Health Minister ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Women who are 28-36 weeks pregnant will have access to the Pfizer-made Abrysvo vaccine, which would normally come at a cost of up to $300. Women who are 28-36 weeks pregnant will have access to ...

This week we welcomed the federal government's announcement that a respiratory syncytial virus (RSV) vaccine for pregnant women would be included on ...